GAMMA Investing LLC Has $5.81 Million Stock Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

GAMMA Investing LLC grew its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 7,291.8% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 176,220 shares of the company’s stock after buying an additional 173,836 shares during the period. GAMMA Investing LLC owned 0.19% of Acadia Healthcare worth $5,812,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in ACHC. JPMorgan Chase & Co. increased its stake in shares of Acadia Healthcare by 17.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company’s stock valued at $198,258,000 after buying an additional 454,044 shares during the period. Blue Trust Inc. increased its stake in shares of Acadia Healthcare by 69.4% in the 4th quarter. Blue Trust Inc. now owns 842 shares of the company’s stock valued at $33,000 after buying an additional 345 shares during the period. Stephens Inc. AR increased its stake in shares of Acadia Healthcare by 25.2% in the 4th quarter. Stephens Inc. AR now owns 5,627 shares of the company’s stock valued at $223,000 after buying an additional 1,134 shares during the period. Beach Point Capital Management LP acquired a new stake in shares of Acadia Healthcare in the 4th quarter valued at $14,097,000. Finally, Rhumbline Advisers increased its stake in shares of Acadia Healthcare by 4.6% in the 4th quarter. Rhumbline Advisers now owns 253,037 shares of the company’s stock valued at $10,033,000 after buying an additional 11,033 shares during the period.

Analysts Set New Price Targets

ACHC has been the subject of a number of research analyst reports. Stephens raised Acadia Healthcare to a “hold” rating in a research note on Monday, June 2nd. Barclays decreased their target price on Acadia Healthcare from $35.00 to $28.00 and set an “equal weight” rating for the company in a research note on Wednesday, May 14th. Royal Bank of Canada decreased their target price on Acadia Healthcare from $64.00 to $43.00 and set an “outperform” rating for the company in a research note on Monday, March 3rd. Guggenheim initiated coverage on Acadia Healthcare in a research note on Wednesday, April 9th. They issued a “buy” rating and a $36.00 target price for the company. Finally, KeyCorp decreased their target price on Acadia Healthcare from $65.00 to $55.00 and set an “overweight” rating for the company in a research note on Wednesday, May 14th. Five equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $47.94.

Acadia Healthcare Stock Down 3.3%

ACHC stock opened at $21.99 on Tuesday. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. The stock has a market capitalization of $2.03 billion, a P/E ratio of 7.21, a P/E/G ratio of 1.46 and a beta of 0.94. The business has a 50-day moving average of $24.18 and a 200-day moving average of $33.58. Acadia Healthcare Company, Inc. has a fifty-two week low of $20.36 and a fifty-two week high of $82.41.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings data on Monday, May 12th. The company reported $0.40 earnings per share for the quarter, topping the consensus estimate of $0.35 by $0.05. The company had revenue of $770.51 million during the quarter, compared to analysts’ expectations of $769.90 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. Acadia Healthcare’s revenue for the quarter was up .3% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.84 earnings per share. On average, sell-side analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.